FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1826176075> ?p ?o ?g. }

• W1826176075 endingPage "564" @default.
• W1826176075 startingPage "558" @default.
• W1826176075 abstract "Study Type – Therapy (economic analysis) Level of Evidence 1b OBJECTIVE To assess and compare the costs and effects value of either starting with sacral neuromodulation (SNM) or botulinum toxin A (BTX) treatment in patients with refractory idiopathic overactive bladder from a societal perspective. MATERIALS AND METHODS An economic model comparing SNM with BTX was developed. A clinical relevant effect (i.e. success) was defined as 50% or greater reduction in incontinence episodes or urgency frequency symptoms. Information on the clinical effectiveness of the two treatments and on the course of the disease with the two treatments were based primarily on published literature and, when required, on expert opinion. Both treatments were assumed to be performed under general anaesthesia and, for SNM treatment, first‐stage tined lead test was used. All costs were based on national data from the year 2008. Analyses from the societal perspective were conducted for a 5‐year duration. Costs were discounted at 4% and effects at 1.5%. In addition, different modelling scenarios were used to see determine any changes in the results obtained. RESULTS Starting with SNM resulted in a higher quality adjusted life year (QALY) gain (differenceof 0.23) and a higher cost (difference of €6428) compared to starting with BTX. The corresponding incremental cost‐effectiveness ratio was €27 991/QALY. The probability of this ratio being cost effective (e.g. under €40 000/QALY) is 88%. SNM starts to be cost‐effective after 4 years. SNM was not cost‐effective in some other scenarios, such as when BTX was conducted under local anaesthesia or when peripheral nerve evaluation or bilateral testing was used for SNM. CONCLUSIONS Starting with SNM, treatment is cost‐effective after 5 years compared to BTX. However, in some scenarios, such as the use of local anaesthesia for BTX treatment and SNM peripheral nerve evaluation or bilateral test, SNM was not cost‐effective." @default.
• W1826176075 created "2016-06-24" @default.
• W1826176075 creator A5013294070 @default.
• W1826176075 creator A5021404933 @default.
• W1826176075 creator A5035635389 @default.
• W1826176075 creator A5060345144 @default.
• W1826176075 date "2010-12-16" @default.
• W1826176075 modified "2023-10-18" @default.
• W1826176075 title "Cost-effectiveness analysis of sacral neuromodulation and botulinum toxin A treatment for patients with idiopathic overactive bladder" @default.
• W1826176075 cites W1967347194 @default.
• W1826176075 cites W1986143238 @default.
• W1826176075 cites W1989913323 @default.
• W1826176075 cites W1995391533 @default.
• W1826176075 cites W1998995174 @default.
• W1826176075 cites W2000655088 @default.
• W1826176075 cites W2009593049 @default.
• W1826176075 cites W2013849774 @default.
• W1826176075 cites W2025114899 @default.
• W1826176075 cites W2034469261 @default.
• W1826176075 cites W2044865711 @default.
• W1826176075 cites W2047833210 @default.
• W1826176075 cites W2053626720 @default.
• W1826176075 cites W2068793140 @default.
• W1826176075 cites W2079232828 @default.
• W1826176075 cites W2094577227 @default.
• W1826176075 cites W2096869731 @default.
• W1826176075 cites W2118214641 @default.
• W1826176075 cites W2122491820 @default.
• W1826176075 cites W2134928141 @default.
• W1826176075 cites W2141005094 @default.
• W1826176075 cites W2150712216 @default.
• W1826176075 cites W2152730379 @default.
• W1826176075 cites W2163587713 @default.
• W1826176075 cites W2164654252 @default.
• W1826176075 cites W4253538317 @default.
• W1826176075 doi "https://doi.org/10.1111/j.1464-410x.2010.09905.x" @default.
• W1826176075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21166750" @default.
• W1826176075 hasPublicationYear "2010" @default.
• W1826176075 type Work @default.
• W1826176075 sameAs 1826176075 @default.
• W1826176075 citedByCount "67" @default.
• W1826176075 countsByYear W18261760752012 @default.
• W1826176075 countsByYear W18261760752013 @default.
• W1826176075 countsByYear W18261760752014 @default.
• W1826176075 countsByYear W18261760752015 @default.
• W1826176075 countsByYear W18261760752016 @default.
• W1826176075 countsByYear W18261760752017 @default.
• W1826176075 countsByYear W18261760752018 @default.
• W1826176075 countsByYear W18261760752019 @default.
• W1826176075 countsByYear W18261760752020 @default.
• W1826176075 countsByYear W18261760752021 @default.
• W1826176075 countsByYear W18261760752022 @default.
• W1826176075 countsByYear W18261760752023 @default.
• W1826176075 crossrefType "journal-article" @default.
• W1826176075 hasAuthorship W1826176075A5013294070 @default.
• W1826176075 hasAuthorship W1826176075A5021404933 @default.
• W1826176075 hasAuthorship W1826176075A5035635389 @default.
• W1826176075 hasAuthorship W1826176075A5060345144 @default.
• W1826176075 hasConcept C112930515 @default.
• W1826176075 hasConcept C141071460 @default.
• W1826176075 hasConcept C142724271 @default.
• W1826176075 hasConcept C159110408 @default.
• W1826176075 hasConcept C204787440 @default.
• W1826176075 hasConcept C2777478456 @default.
• W1826176075 hasConcept C2778941218 @default.
• W1826176075 hasConcept C2779951463 @default.
• W1826176075 hasConcept C3017551082 @default.
• W1826176075 hasConcept C3019080777 @default.
• W1826176075 hasConcept C515549039 @default.
• W1826176075 hasConcept C64332521 @default.
• W1826176075 hasConcept C71924100 @default.
• W1826176075 hasConceptScore W1826176075C112930515 @default.
• W1826176075 hasConceptScore W1826176075C141071460 @default.
• W1826176075 hasConceptScore W1826176075C142724271 @default.
• W1826176075 hasConceptScore W1826176075C159110408 @default.
• W1826176075 hasConceptScore W1826176075C204787440 @default.
• W1826176075 hasConceptScore W1826176075C2777478456 @default.
• W1826176075 hasConceptScore W1826176075C2778941218 @default.
• W1826176075 hasConceptScore W1826176075C2779951463 @default.
• W1826176075 hasConceptScore W1826176075C3017551082 @default.
• W1826176075 hasConceptScore W1826176075C3019080777 @default.
• W1826176075 hasConceptScore W1826176075C515549039 @default.
• W1826176075 hasConceptScore W1826176075C64332521 @default.
• W1826176075 hasConceptScore W1826176075C71924100 @default.
• W1826176075 hasIssue "4" @default.
• W1826176075 hasLocation W18261760751 @default.
• W1826176075 hasLocation W18261760752 @default.
• W1826176075 hasOpenAccess W1826176075 @default.
• W1826176075 hasPrimaryLocation W18261760751 @default.
• W1826176075 hasRelatedWork W2006084043 @default.
• W1826176075 hasRelatedWork W2255662460 @default.
• W1826176075 hasRelatedWork W2558615495 @default.
• W1826176075 hasRelatedWork W2593911270 @default.
• W1826176075 hasRelatedWork W2781638206 @default.
• W1826176075 hasRelatedWork W2796257036 @default.
• W1826176075 hasRelatedWork W3157104042 @default.
• W1826176075 hasRelatedWork W2074932392 @default.
• W1826176075 hasRelatedWork W2600665128 @default.

• next